RxDoctor Payments Data

Shadrick Tillotson

Psychiatric/Mental Health · Lehi, UTNPI 1528514809

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 55 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 13 manufacturers, the largest accounting for just 16.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $637 and has fallen 81.3% since, to $119 in 2024.

$1,025in general payments, 2019–2025

Across 55 payments — averaging $18.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$169
  • AbbVie$148
  • Neurocrine Biosciences, Inc.$137
  • Lundbeck LLC$90
  • Alkermes, Inc.$82
  • Idorsia Pharmaceuticals US Inc$81
  • plus $317 from 7 others

What the payments were for

  • Food & beverage$1,025100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,025 in reported general payments places this provider in the 65th percentile of 393 psychiatric/mental health providers in Utah.

See all psychiatric/mental health providers in Utah →

Medicare billing

Part B allowed, 2024
$7,604
Medicare patients
32
Services billed
90

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Aripiprazole11$572
Bupropion XlBupropion Hcl11$409
Buspirone Hcl23$221

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Lehi

See the full list for Utah →

Where these figures come from

Is this you, or does something look wrong? →